Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-11-18 2:42 pm Unchanged |
2020-11-17 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,765,717 7.800% |
0 (Unchanged) |
Filing History |
| 2020-11-12 5:15 pm Purchase |
2020-11-10 | 13D | Aerpio Pharmaceuticals, Inc. ARPO |
ORBIMED ADVISORS LLC | 346,263 11.000% |
346,263 (New Position) |
Filing History |
| 2020-11-06 5:12 pm Purchase |
2020-10-29 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 110,858 11.300% |
110,858 (New Position) |
Filing History |
| 2020-10-22 8:40 pm Unchanged |
2020-10-22 | 13D | BELLUS Health Inc. BLU |
ORBIMED ADVISORS LLC | 3,954,800 5.200% |
0 (Unchanged) |
Filing History |
| 2020-10-13 9:14 pm Unchanged |
2020-10-13 | 13D | SpringWorks Therapeutics, Inc. SWTX |
ORBIMED ADVISORS LLC | 7,406,307 15.500% |
0 (Unchanged) |
Filing History |
| 2020-10-07 5:08 pm Purchase |
2020-10-02 | 13D | Arcutis Biotherapeutics, Inc. ARQT |
ORBIMED ADVISORS LLC | 4,267,564 9.900% |
200,000 (+4.92%) |
Filing History |
| 2020-10-06 5:16 pm Purchase |
2020-10-01 | 13D | ContextLogic Inc. LOGC |
ORBIMED ADVISORS LLC | 137,566 13.000% |
21,307 (+18.33%) |
Filing History |
| 2020-10-05 5:28 pm Purchase |
2020-09-25 | 13D | Graybug Vision, Inc. GRAY |
ORBIMED ADVISORS LLC | 297,382 20.700% |
297,382 (New Position) |
Filing History |
| 2020-10-05 5:27 pm Purchase |
2020-10-01 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 72,810,381 94.800% |
58,796,060 (+419.54%) |
Filing History |
| 2020-10-05 5:23 pm Purchase |
2020-09-25 | 13D | PMV Pharmaceuticals, Inc. PMVP |
ORBIMED ADVISORS LLC | 6,589,330 14.700% |
6,589,330 (New Position) |
Filing History |
| 2020-10-05 5:17 pm Purchase |
2020-09-25 | 13D | Prelude Therapeutics Incorporated PRLD |
ORBIMED ADVISORS LLC | 14,805,377 33.900% |
14,805,377 (New Position) |
Filing History |
| 2020-09-23 5:00 pm Sale |
2020-09-21 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 1,864,721 9.400% |
-137,500 (-6.87%) |
Filing History |
| 2020-09-18 5:12 pm Purchase |
2020-09-15 | 13D | RESTORBIO INC TORC |
ORBIMED ADVISORS LLC | 5,513,015 28.100% |
682,628 (+14.13%) |
Filing History |
| 2020-08-19 5:14 pm Sale |
2020-08-06 | 13G | ESSA Pharma Inc. EPIX |
ORBIMED ADVISORS LLC | 1,177,483 4.100% |
-294,370 (-20.00%) |
Filing History |
| 2020-08-18 4:31 pm Purchase |
2020-08-10 | 13D | Acutus Medical, Inc. AFIB |
ORBIMED ADVISORS LLC | 5,810,525 20.900% |
5,810,525 (New Position) |
Filing History |
| 2020-07-30 6:26 pm Unchanged |
2020-07-28 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 3,816,206 16.000% |
0 (Unchanged) |
Filing History |
| 2020-07-27 5:57 pm Purchase |
2020-07-17 | 13G | PANDION THERAPEUTICS INC PAND |
ORBIMED ADVISORS LLC | 1,040,825 3.600% |
1,040,825 (New Position) |
Filing History |
| 2020-07-16 5:12 pm Sale |
2020-07-14 | 13D | Alector, Inc. ALEC |
ORBIMED ADVISORS LLC | 2,725,313 3.500% |
-2,776,735 (-50.47%) |
Filing History |
| 2020-07-13 4:20 pm Unchanged |
2020-07-10 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 2,002,221 11.900% |
0 (Unchanged) |
Filing History |
| 2020-07-10 11:55 am Sale |
2020-07-07 | 13D | Alector, Inc. ALEC |
ORBIMED ADVISORS LLC | 5,502,048 7.000% |
-964,944 (-14.92%) |
Filing History |